当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析 - 利润表

戴维医疗

(300314)

  

流通市值:20.72亿  总市值:31.51亿
流通股本:1.89亿   总股本:2.88亿

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入155,328,964.53618,298,238.74458,961,630.27317,308,737.59
营业收入155,328,964.53618,298,238.74458,961,630.27317,308,737.59
利息收入-0--
已赚保费-0--
手续费及佣金收入-0--
二、营业总成本108,971,100.08471,574,505.83343,186,055.45229,652,952.21
营业成本64,421,182.5258,478,134.3192,653,037.88129,765,845.88
利息支出-0--
手续费及佣金支出-0--
退保金-0--
赔付支出净额-0--
保单红利支出-0--
分保费用-0--
税金及附加1,035,494.638,853,445.65,651,111.174,469,874.25
销售费用22,670,944.08121,920,460.2592,293,397.9763,870,825.74
管理费用13,296,577.4454,206,836.2642,019,929.428,808,864.16
研发费用10,287,345.1148,059,212.5927,448,854.1717,114,449.96
财务费用-2,740,443.68-19,943,583.17-16,880,275.14-14,376,907.78
其中:利息费用132,751.17598,807.42450,393.91312,328.02
其中:利息收入2,802,839.8414,540,986.4510,566,329.897,059,704.04
加:公允价值变动收益-263,863.02--
加:投资收益-2,554,623.6711,328,629.4810,825,202.759,938,222.29
汇兑收益-0--
资产处置收益-43,673.56-228,115.57-281,465.8-285,953.66
资产减值损失(新)--2,690,137.06--
信用减值损失(新)-652,079.94-472,598.94-1,135,584.87-610,920.92
其他收益1,381,449.4516,439,286.1213,982,636.857,328,962.04
营业利润平衡项目0000
四、营业利润44,488,936.73171,364,659.96139,166,363.75104,026,095.13
加:营业外收入82,130.68155,550.2242,034.7424,495.89
减:营业外支出140,875.845,295,485.41192,372.1150,999.66
利润总额平衡项目0000
五、利润总额44,430,191.57166,224,724.77139,016,026.39103,899,591.36
减:所得税费用6,322,962.8118,613,813.2616,220,715.3412,122,792.16
六、净利润38,107,228.76147,610,911.51122,795,311.0591,776,799.2
持续经营净利润38,107,228.76147,610,911.51122,795,311.0591,776,799.2
归属于母公司股东的净利润38,107,228.76147,610,911.51122,795,311.0591,776,799.2
(一)基本每股收益0.130.510.430.32
(二)稀释每股收益0.130.510.430.32
八、其他综合收益-0--
归属于母公司股东的其他综合收益-0--
九、综合收益总额38,107,228.76147,610,911.51122,795,311.0591,776,799.2
归属于母公司股东的综合收益总额38,107,228.76147,610,911.51122,795,311.0591,776,799.2
归属于少数股东的综合收益总额-0--
公告日期2024-04-202024-04-092023-10-252023-08-22
审计意见(境内)标准无保留意见
TOP↑